Genomic Vision announced three strategic appointments to its senior management team. M. Stephane Altaba, PhD., is appointed Vice-President Corporate Development With a PhD. in biotechnology from the Ecole Nationale Supérieure d'Agronomie et des Industries Alimentaires (ENSAIA).

Stephane Altaba has over 20 years of experience in strategic positions in pharmaceutical companies. Before joining Genomic Vision, Stephane Altaba was Vice-President Corporate Business Development at Nordic Pharma Group (2006-2015). M. Camille Chypre, PhD., is appointed Vice-President R&D PhD.

in cellular and molecular biology (University of Strasbourg) and biochemical engineer (INSA Lyon), Camille Chypre has over 25 years of experience in positions of responsibility in major international diagnosis companies such as Canadian company DiagnoCure (1997-2005) and American company BioRad (2005-2013). Mrs. Anne Jacquet, PhD., is appointed Medical Director PhD. in pharmacology (Mediterranean University, Marseille) and Doctor of Pharmacy (University of Nantes) Anne Jacquet (46), has over 15 years of experience in preclinical and clinical research in the field of cardiovascular disease and oncology.

She also has an in-depth knowledge of regulatory procedures in Europe and the United States.